Orange Book product · Generic (ANDA)
LIDOCAINE HYDROCHLORIDE
LIDOCAINE HYDROCHLORIDE
At a glance
May 17, 1984
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
May 17, 1984
42 yr 8 mo ago
Today
Pharmaceutical detail
Active ingredient
LIDOCAINE HYDROCHLORIDE
Strength
1.5%
Dosage form
INJECTABLE
Route
INJECTION
TE code
Not listed
Application
ANDA 088330
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of LIDOCAINE HYDROCHLORIDE
- 2008AKTENBrand (NDA)
NDA 022221 · THEA PHARMA
- —LIDOCAINE HYDROCHLORIDEBrand (NDA)
NDA 017508 · ABRAXIS PHARM
- —LIDOCAINE HYDROCHLORIDEBrand (NDA)
NDA 017701 · INTL MEDICATION
- —LIDOCAINE HYDROCHLORIDEBrand (NDA)
NDA 018543 · INTL MEDICATION
- 2026LIDOCAINE HYDROCHLORIDEGeneric (ANDA)
ANDA 220071 · VIWIT PHARM
- 2025LIDOCAINE HYDROCHLORIDEGeneric (ANDA)
ANDA 219535 · ANTHEA PHARMA
- 2023LIDOCAINE HYDROCHLORIDEGeneric (ANDA)
ANDA 217693 · MANKIND PHARMA
- 2023LIDOCAINE HYDROCHLORIDEGeneric (ANDA)
ANDA 217692 · MANKIND PHARMA
- 2022LIDOCAINE HYDROCHLORIDEGeneric (ANDA)
ANDA 215132 · AFAXYS
- 2021LIDOCAINE HYDROCHLORIDEGeneric (ANDA)
ANDA 214336 · ASPIRO
- 2021LIDOCAINE HYDROCHLORIDEGeneric (ANDA)
ANDA 214339 · ASPIRO
- 2020LIDOCAINE HYDROCHLORIDEGeneric (ANDA)
ANDA 212821 · HUONS
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
